LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/ß-Catenin Pathway.

Chen, Binshen; Xu, Kai; Zhang, Yiming; Xu, Peng; Li, Chaoming; Liu, Jun; Xu, Yawen

Chen, Binshen; Xu, Kai; Zhang, Yiming; Xu, Peng; Li, Chaoming; Liu, Jun; Xu, Yawen.

Afiliación

Chen B; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Xu K; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Zhang Y; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Xu P; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Li C; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Liu J; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Xu Y; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.

Cancers (Basel) ; 15(6)2023 Mar 22.

Article en En | MEDLINE | ID: mdl-36980789

Palabras clave

ERVH48-1; WNT2B; docetaxel resistance; miR-4784; prostate cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google